Adjuvant therapy in early stage ER-positive, HER2 - invasive breast cancer

The place of the Oncotype DX Breast Cancer Assay – and the treatment approach

How Recurrence Score result influences treatment decisions

Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3

Treating ALL patients with T cells targeted for CD19

Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence

Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia

Transplantation and short telomeres increase the risk of cognitive impairment

Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease

In vitro and in vivo assessment of anfibatide, a novel glycoprotein ib antagonist